YOLFTbeta
Opthea Ltd

Opthea Ltd

OPT · AU · Healthcare / Biotechnology

0.01AUD-0.00 (-9.09%)

Price History

Full chart

Market Stats

Previous Close0.011
Open0.011
Day Range0.01 – 0.011
52-Week Range0.009 – 0.60
Volume4.26M
Market Cap17.78M
P/E (TTM)0.00
Forward P/E6.75
EPS-0.01
Dividend Yield0.00%
Beta1.53
50-Day Avg0.2367
200-Day Avg0.5092

About

Ceryvyn Therapeutics Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Opthea Limited and changed its name to Ceryvyn Therapeutics Limited in July 2026. Ceryvyn Therapeutics Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
  • Employees33
  • HeadquartersLevel 9, Melbourne, VIC, Australia, 3000, Australia
  • Websitehttps://opthea.com

Leadership

  • Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.CEO & Chairperson · b. 1953
  • Mr. Hamish GeorgeCFO & Joint Company Secretary
  • Dr. Stuart MudgeChief Operating Officer
  • Dr. Michael Gerometta Ph.D.Chief Technology Officer · b. 1965
  • Ms. Stephanie VipondJoint Company Secretary

Financials

Income Statement

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue--------240.51K192.74K2.94B2.62M1.59M9.57K862.00K12.24K13.34K1.10M19.13K14.35K2.37M1.64M--636.20K791.05K578.44K337.64K74.86K145.08K236.81K145.90K127.44K288.24K578.45K392.79K221.83K1.00K
Growth (%)----------19.86%+1524699.67%-99.91%-39.41%-99.40%+8906.38%-98.58%+9.06%+8136.53%-98.26%-24.98%+16414.53%-30.63%---+24.34%-26.88%-41.63%-77.83%+93.80%+63.23%-38.39%-12.65%+126.17%+100.69%-32.10%-43.52%-99.55%
Cost of Revenue-----------27.35K139.00K149.00K256.00K237.00K244.00K509.00K10.00M1.97M2.00M1.13M737.93K1.57M615.51K565.99K344.74K348.41K257.46K258.30K273.94K517.26K571.98K232.47K250.47K---
Gross Profit--------240.51K192.74K2.94B-27.35K-9.57K-12.24K13.34K-19.13K14.35K---737.93K-1.57M20.69K225.06K233.69K-10.77K-182.60K-113.22K-37.13K-371.36K-444.54K55.77K578.45K392.79K221.83K-
Gross Margin--------100.00%100.00%100.00%-1.04%-100.00%-100.00%100.00%-100.00%100.00%----3.25%28.45%40.40%-3.19%-243.93%-78.04%-15.68%-254.53%-348.82%19.35%100.00%100.00%100.00%-
Operating Expense--------1.30M1.42M2.94B520.09K-3.26M-1.80M3.14M-17.11M8.26M--11.19M7.64M7.54M8.81M10.59M9.93M10.94M31.78M36.54M24.13M52.40M139.63M225.83M288.00M236.89M-
Operating Income-504.34K-635.35K-164.12K-73.20K-74.81K-80.38K-525.55K-970.99K-1.06M-1.23M-741.67K-547.44K-833.01K-3.25M-2.97M-1.78M-3.12M-5.32M-17.09M-8.25M-11.20M-10.83M-11.93M-9.20M-7.52M-8.58M-10.36M-9.94M-11.12M-31.90M-36.58M-24.50M-52.84M-139.58M-225.25M-287.61M-236.66M-11.95M
Operating Margin---------439.91%-638.09%-0.03%-20.89%-52.46%-33943.73%-344.38%-14580.23%-23410.08%-484.31%-89357.99%-57478.29%-472.76%-658.83%---1182.14%-1084.81%-1790.74%-2944.97%-14859.21%-21985.03%-15447.65%-16795.79%-41464.66%-48423.67%-38939.98%-73222.21%-106686.49%-1194700.00%
EBITDA-511.89K-627.42K-163.35K-72.46K-66.80K-78.92K-522.00K-967.05K-1.05M192.74K-726.78K-534.34K-807.29K29.00K-2.94M-1.76M16.80M-5.31M-14.36M-8.22M-11.17M-10.80M-11.90M-9.18M-7.49M-6.79M-8.77M-7.72M-9.80M-29.74M-36.64M-24.68M-52.85M-139.81M-225.22M-287.58M-236.65M-
EBITDA Margin---------437.09%100.00%-0.02%-20.39%-50.84%303.00%-341.26%-14362.89%125917.96%-483.06%-75065.06%-57269.40%-471.32%-657.09%---1177.84%-858.12%-1515.72%-2285.42%-13088.66%-20496.36%-15470.52%-16914.89%-41468.58%-48504.56%-38935.57%-73214.96%-106681.70%-
Net Income-410.72K-492.57K-138.81K-60.51K-341.35K-45.30K-472.28K-857.59K-1.05M-1.23M1.58M730.42K-801.17K-3.23M-2.36M4.06M16.60M-4.80M9.50M-1.10M-8.00M-5.91M-10.97M-4.95M-4.75M-4.00M-5.31M-6.51M-6.19M-16.90M-20.91M-16.12M-60.47M-134.44M-213.98M-330.19M-247.34M330.44M
Net Income Margin---------438.08%-638.09%0.05%27.87%-50.45%-33785.77%-274.11%33157.78%124404.80%-437.02%49675.59%-7652.13%-337.69%-359.19%---747.37%-505.17%-918.35%-1927.31%-8272.64%-11650.37%-8829.93%-11047.04%-47450.15%-46640.86%-36992.10%-84061.92%-111500.89%33044500.00%
R&D--7.67K------600.34K358.33K186.15K553.00K144.72K106.50K349.78K533.75K1.62M2.67M3.27M3.62M4.30M6.57M3.60M5.59M5.45M7.21M5.87M6.23M27.11M31.35M17.48M34.53M113.92M193.42M264.35M192.71M2.21M
R&D as % of Total Revenue---------311.48%0.01%7.10%34.82%1512.05%12.36%2858.81%4000.23%147.31%13980.89%22795.39%152.67%261.27%--879.08%688.33%1246.50%1739.88%8321.33%18687.15%13237.63%11981.40%27094.19%39523.85%33438.22%67300.07%86871.39%220500.00%
Interest Expense7.55K3.96K5.37K2.24K6681.46K1.42K787.51.40M1.98M4.69M1.28M8.16K1.12K521.97K5.87M179.45K71.87K52.26M12.68M391.82K4.36M576.11K1.54M1.49M000001.09M14.49K21.65M235.47K20.01M30.26M46.46M11.06M
Interest Expense % of Total Revenue--------581.91%1027.85%0.16%48.75%0.51%11.73%60.55%47955.35%1344.88%6.54%273189.40%88334.84%16.53%265.18%--233.80%0.00%0.00%0.00%0.00%0.00%461.94%9.93%16991.88%81.69%3459.87%7704.64%20942.42%1105900.00%

Balance Sheet

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets2.45M1.53M1.32M1.67M1.64M2.13M2.14M3.93M5.49M4.49M7.30M15.22M24.37M23.49M24.83M29.46M32.92M43.79M56.71M51.52M33.31M29.46M26.19M23.13M14.98M11.73M18.46M17.05M56.54M46.08M37.66M71.89M184.36M87.32M148.19M188.79M56.80M31.93M
Total Liabilities34.73K25.38K29.14K38.84K21.38K32.15K68.89K95.29K167.27K161.94K142.11K218.09K165.85K208.87K318.25K312.34K4.29M1.72M5.00M2.34M2.02M2.42M2.86M2.46M1.87M1.87M1.80M2.07M2.05M7.90M6.54M7.08M4.16M17.55M156.98M264.60M257.87M2.32M
Total Equity2.45M1.51M1.32M1.65M1.63M2.10M2.07M3.83M5.32M2.69M7.16M15.00M23.97M23.28M24.51M29.15M28.52M41.99M47.37M45.37M31.27M27.04M23.32M19.35M12.28M9.54M16.03M14.98M54.49M38.17M31.12M64.81M180.20M69.77M-8.79M-75.81M-201.07M29.61M
Cash25.67K4.76K200.00K520.00K680.00K31.42K39.06K9.45K107.15K85.86K109.60M274.60K12.97M11.26M9.89M12.19M18.82M10.84M40.88M44.22M31.34M27.07M23.62M16.82M10.04M6.74M14.14M14.49M51.96M32.51M21.53M62.02M157.43M64.90M133.99M172.47M48.44M30.02M
Total Debt--7.67K20.17K668--10.24K2.86K-------3.81M--------------264.14K112.97K-85.89M141.65M376.89M-
Net Debt-25.67K-4.76K-192.33K-499.83K-679.33K-31.42K-39.06K786.99-104.30K-85.86K-109.60M-274.60K-12.97M-11.26M-9.89M-12.19M-15.01M-10.84M-40.88M-44.22M-31.34M-27.07M-23.62M-16.82M-10.04M-6.74M-14.14M-14.49M-51.96M-32.51M-21.53M-61.76M-157.28M-64.90M-133.71M-30.82M-48.44M-

Cash Flow

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow---197.00K-267.00K-351.00K-469.00K-672.00K-1.22M-1.74M----1.01M-1.04M--1.71M-1.64M-2.89M32.97M-1.80M-6.59M-7.54M-9.42M-7.17M-5.61M-4.17M-5.03M-3.68M-6.05M-19.94M-24.19M-8.78M-45.84M-71.33M-119.08M-161.02M-158.64M-
Investing Cash Flow-----135.60K126.41K-75.28K61.42K-84.72K-44.79K-7.36K-3.41M-5.97M-2.17M-1.72M3.46M22.73M-1.61M-55.47K-66.18K-597.28K515.73K-65.86K402.52K212.59K342.13K39.19K-203.20K168.54K-34.42K320.98K475.74K656.48K-16.91K-32.64K-33.49K-13.00K-
Financing Cash Flow---425.79K494.32K365.35K532.65K2.39M1.40M612.53K304.67K9.60M12.17M65.31K-983.60K-342.05K-15.96M-3.72M576.55K-104.75K1.27M1.08M-647.45K1.02M490.57K16.05M16.05M4.21K43.41M549.65K12.63M48.98M116.94M171.60K167.28M243.73M34.77M-30.89M
Capital Expenditure000008.04K4.26K7.88K44.95K72.15K12.46M14.65K26.02K12.38K15.11K4.10K6.89K12.23K56.06K30.86K11.95K19.68K82.16K39.40K2.73K111.12K411.72K3.08K34.42K18.07K3.67K17.03K23.32K32.64K33.49K13.00K0
Free Cash Flow---197.00K-267.00K-351.00K-477.04K-676.26K-1.22M-1.79M-72.15K-12.46M-14.65K-1.03M-1.05M-15.11K-1.71M-1.64M-2.90M32.92M-1.83M-6.60M-7.56M-9.50M-7.21M-5.62M-4.29M-5.03M-3.69M-6.05M-19.97M-24.20M-8.25M-61.08M-98.39M-179.34M-161.05M-158.66M-12.50M
Dividends Paid----------------10.78M4.00K3.95K39.41K-------00---------
FCF to OCF--100.00%100.00%100.00%101.71%100.63%100.65%102.58%---102.59%101.19%-100.24%100.42%100.42%99.83%101.72%100.18%100.26%100.87%100.55%100.05%102.66%100.00%100.32%100.05%100.17%100.07%93.92%133.23%137.93%150.61%100.02%100.01%-
Dividend Paid to FCF-----------------656.16%-0.14%0.01%-2.15%-------0.00%0.00%---------

Earnings

Report DateFeb 15, 2016Aug 15, 2016Nov 30, 2016Feb 20, 2017Aug 29, 2017Feb 18, 2018May 30, 2018Aug 27, 2018Nov 28, 2018Feb 24, 2019May 29, 2019Aug 8, 2019Nov 27, 2019Feb 25, 2020Jun 3, 2020Aug 27, 2020Dec 2, 2020Feb 21, 2021Jun 2, 2021Aug 29, 2021Dec 1, 2021Feb 27, 2022Jun 1, 2022Aug 30, 2022Nov 30, 2022Feb 23, 2023May 31, 2023Feb 27, 2025Aug 28, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.090.000.000.000.000.000.050.00-0.090.00-0.090.00-0.12-0.07
EPS Actual-0.01-0.03-0.12-0.02-0.02-0.060.00-0.030.00-0.050.00-0.040.00-0.030.00-0.060.020.020.030.040.00-0.110.000.000.000.000.00-0.11-0.03
Surprise---------------33.33%1041.18%7950.00%11533.33%10225.00%--320.00%-100.00%-100.00%-8.33%57.14%
Timing---------------------After-hours-After-hours-After-hours--Pre-market

Key Statistics & Ratios

Market Cap17.78M
Enterprise Value55.78M
Trailing P/E0.00
Forward P/E6.75
PEG Ratio0.65
Price / Sales5621.83
Price / Book0.51
EPS-0.01
Book Value0.025
Revenue (TTM)-20.12K
Gross Profit (TTM)-20.12K
EBITDA-109.39M
Profit Margin0.00%
Operating Margin-706200.00%
Return on Equity-3383.08%
Return on Assets-50.44%
Shares Outstanding1.37B
Shares Float1.15B
Beta1.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
8.38%
Insiders
25.94%
Retail / Other
65.68%

Top Fund Holders

  • Vanguard International Stock Index-Total Intl Stock Indx
    3.60M1.04%
  • Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
    2.14M0.62%
  • Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index
    738.02K0.21%
  • Schwab Strategic Tr-Schwab International Small Cap Equity ETF
    371.24K0.11%
  • Vanguard International Stock Index-Pacific Stock Index
    238.46K0.07%
  • Vanguard Intl Equity Index - Total World Stock Index Fd
    93.16K0.03%
  • SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF
    79.13K0.02%

Dividends

20051×
0.13Feb 4, 2005
20041×
0.32Oct 11, 2004

Stock Splits

  • Jun 14, 202410995:10127
  • Aug 28, 20231221:1151
  • Oct 13, 2014133:130